The Longevity Science Foundation is extending its fundraising campaign for the Invested in Her project until 1 October 2026. With this campaign, they aim to raise $250,000 for research into ovarian ageing and the menopause. These topics are important because they have a major impact on women's health as they get older, yet to date they have received too little attention and funding.
On average, women live longer than men, but spend more years dealing with health problems. This is linked to changes in hormone levels during the menopause and the ageing of the ovaries. This transition affects several key systems in the body, such as the heart, the brain and the bones. Understanding this process is therefore essential for better prevention and treatment.
At present, only a small portion of research funding goes towards health research specifically aimed at women, and even less of that towards ovarian ageing and the menopause. The Longevity Science Foundation wants to change this by not only supporting therapies, but also studying how to measure ovarian ageing and early intervention. This will enable science to make faster progress.
Recently, a broad group of specialists, investors and advocates came together to discuss this topic. They emphasised that changes in healthcare and additional funding are necessary to enable better care for women. The campaign ensures that donations go entirely towards the research, with no costs for the organisation.
This research is of great importance for healthy ageing, as it can help keep women vital and healthy for longer after the menopause.
Source: Press release
